You are here: Industry Insights > vaccine

News List

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum prnasia
November 24, 2021
Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx) has announced financial results for the third quarter ended September 30, 2021.
Nykode Therapeutics partners with Regeneron to develop cancer and infectious disease vaccines PharmaTimes
November 24, 2021
Nykode Therapeutics, a clinical-stage biopharmaceutical company, announced that it has entered into a collaboration agreement with Regeneron.
Valneva Inks APA with European Commission for COVID Vax ContractPharma
November 24, 2021
Valneva SE, a specialty Vaccine company, has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate...
SII urges govt to fast-track movement of increasing Covishield stock ExpressPharma
November 24, 2021
The Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines...
No scientific evidence to support need for booster vaccine dose against COVID, says ICMR chief ExpressPharma
November 24, 2021
There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, Dr Balram Bhargava, Director General, ICMR, said recently underlining the completion of second dose...
UK recognises Covaxin as valid COVID-19 vaccine for travel PharmaTimes
November 23, 2021
Travellers vaccinated with Bharat Biotech’s Covaxin will now be able to enter the UK, as the vaccine has been added to the approved list. This means that those inoculated with Covaxin...
New Data From Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 -15 AmericanPharmaceuticalReview
November 23, 2021
Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to four nations ExpressPharma
November 23, 2021
The Union government has allowed the Serum Institute of India (SII) to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine programme to Nepal, Tajikistan and Mozambique, official sources said.
Pfizer Says Its COVID Vaccine Provides Full Protection to Adolescents Drugs
November 23, 2021
Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants.
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time prnasia
November 22, 2021
At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological Products Co., Ltd. will depart from...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page